Walleye Capital’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-533,884
| Closed | -$3.2M | – | 1951 |
|
|
2025
Q1 | $3.2M | Sell |
533,884
-402,907
| -43% | -$2.41M | 0.01% | 480 |
|
|
2024
Q4 | $7.31M | Buy |
936,791
+379,465
| +68% | +$2.96M | 0.02% | 338 |
|
|
2024
Q3 | $6.02M | Buy |
+557,326
| New | +$6.02M | 0.01% | 392 |
|
|
2023
Q4 | – | Sell |
-552,908
| Closed | -$5.39M | – | 2311 |
|
|
2023
Q3 | $5.39M | Sell |
552,908
-44,318
| -7% | -$432K | 0.01% | 367 |
|
|
2023
Q2 | $7.07M | Sell |
597,226
-189,370
| -24% | -$2.24M | 0.03% | 224 |
|
|
2023
Q1 | $8.49M | Buy |
786,596
+342,493
| +77% | +$3.7M | 0.13% | 169 |
|
|
2022
Q4 | $5.13M | Buy |
444,103
+309,955
| +231% | +$3.58M | 0.09% | 247 |
|
|
2022
Q3 | $2M | Buy |
134,148
+123,559
| +1,167% | +$1.84M | 0.04% | 449 |
|
|
2022
Q2 | $96K | Buy |
+10,589
| New | +$96K | ﹤0.01% | 1716 |
|